MicroRNA expression profiling in canine prostate cancer

J Vet Med Sci. 2017 Apr 5;79(4):719-725. doi: 10.1292/jvms.16-0279. Epub 2017 Feb 27.

Abstract

Canine prostate cancer (cPCa) is an untreatable malignant neoplasm resulting in local tissue invasion and distant metastasis. MicroRNAs (miRs) are small non-coding RNAs that function as oncogenes or tumor suppressors. The purpose of this study was to characterize the expression of miRs that are altered in cPCa tissue. The expression levels of 277 mature miRs in prostatic tissue (n=5, respectively) were compared between the non-tumor and tumor groups using real-time PCR. Five miRs (miR-18a, 95, 221, 222 and 330) were up-regulated, but 14 miRs (miR-127, 148a, 205, 299, 329b, 335, 376a, 376c, 379, 380, 381, 411, 487b and 495) were down-regulated specifically in cPCa (P<0.05). These miRs have potential use as early diagnosis markers for cPCa and in miR-based therapy.

MeSH terms

  • Animals
  • Dog Diseases / genetics*
  • Dogs
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Male
  • MicroRNAs / biosynthesis
  • MicroRNAs / genetics*
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / veterinary*
  • RNA, Neoplasm / biosynthesis
  • RNA, Neoplasm / genetics*
  • Real-Time Polymerase Chain Reaction / veterinary

Substances

  • MicroRNAs
  • RNA, Neoplasm